Powered by

Diagnostics

The latest articles, press releases and dossiers on diagnostics in Baden-Württemberg

  • Article - 29-Oct-2012

    Tilman Schäffer at the University of Tübingen creates a bridge between physics, biology and medicine. His speciality is innovative microscopic detection methods such as atomic force microscopy. In addition to application, Schäffer is working on improving scanning probe microscopy instrumentation and methods.

  • Press release - 26-Oct-2012

    Europe-wide network for investigating irritable bowel syndrome headed by Heidelberg University HospitalEuropean Science Foundation provides 500000 euros in funding for understanding causes improving options for diagnosis and treatment.

  • Article - 22-Oct-2012

    Functional medical imaging modalities are of great significance in modern medical diagnostics. Existing ways of diagnosing diseases are now being expanded with the arrival of the innovative parameter imaging method. syneed imaging uses proprietary highly sensitive software for the analysis of dynamic image data. This software complements standard methods such as computed tomography and magnetic resonance imaging and increases the significance of image data in clinical trials and therapy decisions.

  • Article - 15-Oct-2012

    Detecting viruses, bacteria or parasites in human, animal, food and environmental samples is routine for the staff of gerbion GmbH & Co. KG. The company has been using virological, microbiological and serological methods for many years, but is now also using cutting-edge molecular biology methods for detecting pathogens. The founders of the Kornwestheim-based diagnostics company have concentrated on own research work and the development of new detection methods and tests right from the word go.

  • Article - 08-Oct-2012

    On the occasion of its 50th anniversary, the Institute of Human Genetics at the University Hospital of Heidelberg celebrates its major achievements in molecular genetic analyses, the diagnosis of hereditary diseases and tumour diseases as well as its research into the molecular causes of genetic defects. The largest institute of human genetics in Germany is also at the forefront of genetic counselling and debates on health policies and ethical issues.

  • Article - 01-Oct-2012

    How will laboratory automation develop in the future? What challenges need to be tackled, what are the requirements of laboratory automation users and how can automation technology contribute to making laboratory processes more efficient and more reliable? These and many other questions were discussed in detail at the “Lab Automation Symposium” which was jointly organised by BIOPRO Baden-Württemberg and Festo and held on 20th September 2012.

  • Article - 24-Sep-2012

    Down syndrome, or trisomy 21, occurs when there is an extra copy of chromosome 21. LifeCodexx AG has developed PraenaTest®, an innovative diagnostic test that is able to reliably confirm or exclude trisomy 21 from a blood sample of a pregnant woman. The non-invasive test developed by the Konstanz-based biotech company has recently been placed on the market as an alternative to current invasive tests which result in up to 700 miscarriages per year in Germany alone.

  • Press release - 21-Sep-2012

    Patients with oropharyngeal cancers have a more favorable prognosis if their tumors are caused by human papillomaviruses. Scientists from the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) and Heidelberg University Hospital have now identified biomarkers which enable them to differentiate cancer cases taking a favorable course from those with an unfavorable one. It may be possible to treat the two disease types differently.

  • Article - 06-Aug-2012

    The bachelor’s theses of Matthias Hillert and Pascal Laube, students at the Konstanz University of Applied Sciences (HTWG), involved the development of a computer programme that facilitates the analysis of computed tomography images of the liver by comparing them to similar images stored in a database. It is a tool that has the potential to be used in other areas, such as the identification of bone tumours.

  • Press release - 01-Aug-2012

    SYGNIS Pharma AG and GENETRIX announced today, that the biotechnology companies SYGNIS and GENETRIX have signed a binding Term Sheet under which the companies propose to combine the GENETRIX’ DNA sequencing subsidiary X-Pol Biotech and SYGNIS. Goal is to develop and market X-Pol Biotech, S.L.’s DNA sequencing technologies and products.

  • Press release - 17-Jul-2012

    The world's first commercial detection method for the Schmallenberg virus is now available for all laboratories. Kornwestheim-based AnDiaTec GmbH & Co. KG, specialists in detection methods for pathogens in the veterinary field, has just received approval for its product from the Friedrich-Löffler-Institut under the German Ordinance on Working with Animal Pathogens (Tierseuchengesetz). The virus, which has led, among other things, to stillbirths and miscarriages in livestock such as cattle and sheep throughout the whole of Europe in the last few months, can now be detected quickly and reliably.

  • Dossier - 09-Jul-2012

    More practical relevance, shorter courses and courses that are compatible across Europe – when the decision to implement the bachelor’s and master’s system was made in Germany in 1999, there were high expectations and hopes for the positive changes to come. The question is, have these expectations been met? The time is now ripe for universities and companies to review the progress that has been made in achieving the goals of the Bologna Declaration.

Website address: https://www.gesundheitsindustrie-bw.de/en/article/diagnostics/?block_75783size=12&block_75783from=108